192 related articles for article (PubMed ID: 31897899)
21. Microfluidic-assisted nanoprecipitation of (PEGylated) poly (d,l-lactic acid-co-caprolactone): Effect of macromolecular and microfluidic parameters on particle size and paclitaxel encapsulation.
Lallana E; Donno R; Magrì D; Barker K; Nazir Z; Treacher K; Lawrence MJ; Ashford M; Tirelli N
Int J Pharm; 2018 Sep; 548(1):530-539. PubMed ID: 30009983
[TBL] [Abstract][Full Text] [Related]
22. Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization.
Chow SF; Wan KY; Cheng KK; Wong KW; Sun CC; Baum L; Chow AH
Eur J Pharm Biopharm; 2015 Aug; 94():436-49. PubMed ID: 26143368
[TBL] [Abstract][Full Text] [Related]
23. [Characterization of Me. PEG-PLA copolymer nanoparticles prepared by modified spontaneous emulsion-solvent evaporation].
Dong J; Liu MX; Yang YJ; Xu HB; Yang XL
Yao Xue Xue Bao; 2004 Sep; 39(9):677-80. PubMed ID: 15606012
[TBL] [Abstract][Full Text] [Related]
24. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
25. Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.
Feng J; Markwalter CE; Tian C; Armstrong M; Prud'homme RK
J Transl Med; 2019 Jun; 17(1):200. PubMed ID: 31200738
[TBL] [Abstract][Full Text] [Related]
26. Engineered Polymer-Supported Biorthogonal Nanocatalysts Using Flash Nanoprecipitation.
Huang R; Hirschbiegel CM; Zhang X; Gupta A; Fedeli S; Xu Y; Rotello VM
ACS Appl Mater Interfaces; 2022 Jul; 14(28):31594-31600. PubMed ID: 35802797
[TBL] [Abstract][Full Text] [Related]
27. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
28. PCL/PEG core/sheath fibers with controlled drug release rate fabricated on the basis of a novel combined technique.
Yu H; Jia Y; Yao C; Lu Y
Int J Pharm; 2014 Jul; 469(1):17-22. PubMed ID: 24751343
[TBL] [Abstract][Full Text] [Related]
29. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
Daman Z; Ostad S; Amini M; Gilani K
Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
[TBL] [Abstract][Full Text] [Related]
30. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics.
Gu L; Faig A; Abdelhamid D; Uhrich K
Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069
[TBL] [Abstract][Full Text] [Related]
31. Rational Mitomycin Nanocarriers Based on Hydrophobically Functionalized Polyelectrolytes and Poly(lactide-
Lamch Ł; Wilk KA; Dékány I; Deák Á; Hornok V; Janovák L
Langmuir; 2022 May; 38(18):5404-5417. PubMed ID: 35442685
[TBL] [Abstract][Full Text] [Related]
32. Triple Redox Responsive Poly(Ethylene Glycol)-Polycaprolactone Polymeric Nanocarriers for Fine-Controlled Drug Release.
Zhao C; Shao L; Lu J; Zhao C; Wei Y; Liu J; Li M; Wu Y
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27762492
[TBL] [Abstract][Full Text] [Related]
33. Preparation of Drug-Loaded PLGA-PEG Nanoparticles by Membrane-Assisted Nanoprecipitation.
Albisa A; Piacentini E; Sebastian V; Arruebo M; Santamaria J; Giorno L
Pharm Res; 2017 Jun; 34(6):1296-1308. PubMed ID: 28342057
[TBL] [Abstract][Full Text] [Related]
34. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
[TBL] [Abstract][Full Text] [Related]
35. Organic solvent-free low temperature method of preparation for self assembled amphiphilic poly(ϵ-caprolactone)-poly(ethylene glycol) block copolymer based nanocarriers for protein delivery.
Payyappilly SS; Panja S; Mandal P; Dhara S; Chattopadhyay S
Colloids Surf B Biointerfaces; 2015 Nov; 135():510-517. PubMed ID: 26291587
[TBL] [Abstract][Full Text] [Related]
36. Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis.
Jogala S; Rachamalla SS; Aukunuru J
Curr Drug Deliv; 2016; 13(5):698-710. PubMed ID: 26777886
[TBL] [Abstract][Full Text] [Related]
37. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
[TBL] [Abstract][Full Text] [Related]
38. Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab.
Savin CL; Popa M; Delaite C; Costuleanu M; Costin D; Peptu CA
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():843-860. PubMed ID: 30813091
[TBL] [Abstract][Full Text] [Related]
39. Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method.
Almoustafa HA; Alshawsh MA; Chik Z
Int J Pharm; 2017 Nov; 533(1):275-284. PubMed ID: 28943210
[TBL] [Abstract][Full Text] [Related]
40. Nanocarriers for photodynamic therapy-rational formulation design and medium-scale manufacture.
Villa Nova M; Janas C; Schmidt M; Ulshoefer T; Gräfe S; Schiffmann S; de Bruin N; Wiehe A; Albrecht V; Parnham MJ; Luciano Bruschi M; Wacker MG
Int J Pharm; 2015 Aug; 491(1-2):250-60. PubMed ID: 26123822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
